BANK VONTOBEL/CALL/MERCK & CO./110/0.1/21.06.24 Share Price

Warrant

DE000VM524H4

Real-time Boerse Frankfurt Warrants 15:44:55 13/05/2024 BST
1.81 EUR -8.12% Intraday chart for BANK VONTOBEL/CALL/MERCK & CO./110/0.1/21.06.24
1 month+17.26%
3 months+16.57%
Date Price Change Volume
13/05/24 1.81 -8.12% 0
10/05/24 1.97 +0.51% 0
09/05/24 1.96 +2.62% 0
08/05/24 1.91 +2.69% 0
07/05/24 1.86 +8.77% 0

Real-time Boerse Frankfurt Warrants

Last update May 13, 2024 at 03:44 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM524H
ISINDE000VM524H4
Date issued 28/11/2023
Strike 110 $
Maturity 21/06/2024 (39 Days)
Parity 10 : 1
Emission price 0.32
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.27
Lowest since issue 0.26
Spread 0.01
Spread %0.56%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.1 USD
Average target price
141.6 USD
Spread / Average Target
+8.90%
Consensus